Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Aug 15;13(16):4113. doi: 10.3390/cancers13164113

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Survival outcome of AML patients according to response to APVO436. Depicted are the overall survival curves of the 8 patients’ favorable responses, 31 patients who did not respond, and all 39 patients combined. Favorable responses of CR, PR, or SD ≥ 3 months was associated with improved overall survival in R/R AML patients treated with APVO436 monotherapy.